Short Interest in Movano Inc. (NASDAQ:MOVE) Drops By 22.5%

Movano Inc. (NASDAQ:MOVE) saw a large drop in short interest during the month of March. As of March 31st, there was short interest totaling 8,373 shares, a drop of 22.5% from the March 15th total of 10,802 shares. Based on an average trading volume of 42,936 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.8% of the shares of the company are short sold.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Wall Street Zen raised Movano from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. Weiss Ratings reissued a “sell (e+)” rating on shares of Movano in a report on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Movano presently has a consensus rating of “Sell”.

Key Stories Impacting Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Technical/momentum interest — MOVE crossed above its 50‑day ($13.09) and 200‑day ($10.36) moving averages, which can trigger momentum and breakout buying in small‑cap names and attract short‑covering. (Technical action, not a company fundamental update.)
• Neutral Sentiment: Broader market risk‑on mood — major indexes and sentiment indicators have been positive recently, which lifts speculative small caps and health/tech names; that environment can amplify short‑term rallies in tiny stocks like MOVE. S&P 500 Settles At New Record High
• Neutral Sentiment: Sector headlines can shift flow into health/consumer‑tech plays — recent positive news for consumer/health peers (e.g., FDA peptide review boosting Hims & Hers) can nudge investor attention toward adjacent wearable/medical device names. Hims & Hers Stock Boosts on FDA Peptide Review
• Negative Sentiment: Weak fundamentals remain a major risk — Movano reported a large quarterly EPS loss (-$5.88) and revenue of only $0.04M vs. consensus ~$7.6M in its March quarter, with an extremely negative net margin and ROE. Those figures leave the company vulnerable to any pullback and make gains fragile. Movano (MOVE) profile
• Negative Sentiment: Low market cap / thin liquidity — with a market cap around $18.6M and below‑average trading volume today, MOVE is prone to outsized moves from small orders, promotional activity, or short squeezes; that elevates both upside speed and downside risk.

Movano Stock Performance

NASDAQ MOVE traded up $0.51 during trading hours on Friday, hitting $16.40. The company had a trading volume of 64,872 shares, compared to its average volume of 113,944. Movano has a 52 week low of $3.44 and a 52 week high of $25.69. The firm has a 50 day simple moving average of $13.14 and a 200 day simple moving average of $10.44. The firm has a market capitalization of $18.53 million, a price-to-earnings ratio of -1.55 and a beta of 0.71.

Movano (NASDAQ:MOVE) last issued its earnings results on Monday, March 30th. The technology company reported ($5.88) EPS for the quarter, missing the consensus estimate of ($3.60) by ($2.28). Movano had a negative return on equity of 647.91% and a negative net margin of 4,231.41%.The company had revenue of $0.04 million during the quarter, compared to the consensus estimate of $7.63 million.

Insider Activity

In related news, CEO John Mastrototaro sold 33,069 shares of Movano stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $20.80, for a total value of $687,835.20. Following the completion of the sale, the chief executive officer owned 56,114 shares of the company’s stock, valued at approximately $1,167,171.20. This trade represents a 37.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jeremy Cogan sold 28,736 shares of Movano stock in a transaction dated Tuesday, January 27th. The stock was sold at an average price of $20.78, for a total value of $597,134.08. Following the completion of the sale, the chief financial officer directly owned 60,504 shares of the company’s stock, valued at approximately $1,257,273.12. This trade represents a 32.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC bought a new position in Movano Inc. (NASDAQ:MOVE) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano as of its most recent SEC filing. Institutional investors own 16.64% of the company’s stock.

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.